Tayyiaba Iqbal
Tayyiaba Iqbal publishes mostly in Organic Chemistry, Computational Theory and Mathematics and Pharmacology, on topics such as Synthesis and biological activity, Computational Drug Discovery Methods and Cholinesterase and Neurodegenerative Diseases.
- World rank
- #557,119 of 7,710,434 ranked researchers
- Rank in Pakistan
- #1,644 of 32,975
- Works
- 99
- Citations
- 890
- Citations per work
- 9.0
What does Tayyiaba Iqbal research?
Tayyiaba Iqbal's work is mostly in Chemistry (44%), Medicine (19%), Computer Science (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences5656.9%
- Chemistry4444.1%
- Computer Science1312.8%
- Health Sciences1919.3%
- Medicine1919.3%
- Everything else1514.8%
- Life Sciences99.0%
- 1Organic Chemistry44% of their works
- 2Computational Theory and Mathematics13% of their works
- 3Pharmacology12% of their works
- 4Molecular Biology9% of their works
- 5Endocrinology, Diabetes and Metabolism5% of their works
- 6Oncology2% of their works
Research topics
- Synthesis and biological activity
- Computational Drug Discovery Methods
- Cholinesterase and Neurodegenerative Diseases
- Click Chemistry and Applications
- Natural Antidiabetic Agents Studies
- Enzyme function and inhibition
- Synthesis and Characterization of Heterocyclic Compounds
- Biochemical and Molecular Research
Which keywords describe Tayyiaba Iqbal's research?
The keywords of their largest research topics: Medicinal Chemistry, Anticancer Agents, Heterocyclic Compounds, Tubulin Inhibitors, Drug Discovery, Molecular Docking, Drug Target Identification and Virtual Screening.
- Nucleotide Metabolism
- Triazines
- Inhibitors
- Oxidative Stress
- Copper-Catalyzed Cycloaddition
- Cholinesterase Inhibitors
- Virtual Screening
- Molecular Docking
- Tubulin Inhibitors
- Anticancer Agents
- Medicinal Chemistry
- Heterocyclic Compounds
- Drug Discovery
- Drug Target Identification
- Acetylcholinesterase
- Click Chemistry
- Diabetes
- Carbonic Anhydrases
- Synthesis
- Enzyme Regulation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Medicinal Chemistry1002 topics
- Anticancer Agents752 topics
- Heterocyclic Compounds631 topic
- Tubulin Inhibitors631 topic
- Drug Discovery493 topics
- Molecular Docking482 topics
- Drug Target Identification371 topic
- Virtual Screening371 topic
- Acetylcholinesterase321 topic
- Cholinesterase Inhibitors321 topic
- Click Chemistry261 topic
- Copper-Catalyzed Cycloaddition261 topic
- Diabetes141 topic
- Oxidative Stress141 topic
- Carbonic Anhydrases121 topic
- Inhibitors121 topic
- Synthesis111 topic
- Triazines111 topic
- Enzyme Regulation51 topic
- Nucleotide Metabolism51 topic
Where does Tayyiaba Iqbal work?
Tayyiaba Iqbal's main affiliation in the publication record is Abbottabad University of Science and Technology, Pakistan.
How many publications and citations does Tayyiaba Iqbal have?
OpenAlex counts 99 works and 890 citations for Tayyiaba Iqbal, an h-index of 16, ranking #557,119 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tayyiaba Iqbal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.